Windlas Biotech Ltd

NSE: WINDLAS · BSE: 543329 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹1,036.20
Market cap: ₹2,175 Cr
Revenue (annual): ₹904.1 Cr
Net profit (annual): ₹66.44 Cr
P/E (TTM): 32.7×Sector 47.4×
Promoter holding: 63.31%+1.41% QoQ
FII holding: 2.04%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 10 Earnings Call 4 Financial Results 3 Results Update 2 Other Announcement 2 Management Change 2 Annual General Meeting 2 Employee Stock Options 1 Dividend 1 Debt & Borrowing 1 Credit Rating 1 Board Meeting Outcome 1 Board Meeting Date 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

23 Jul 2026 14:59 IST BSE

Annual General Meeting

Windlas Biotech Annual General Meeting

Windlas Biotech Ltd held its 25th Annual General Meeting on July 23, 2026. Shareholders approved the financial statements and a final dividend of Rs. 6.30 per share.

Read the filing ↗

1 Jul 2026 12:37 IST BSE

Annual General Meeting

Windlas Biotech Annual General Meeting

Windlas Biotech Ltd announced a dividend of Rs.6.30 per share (126% of face value) for FY 2025-26. Record date is set for July 16, 2026.

Read the filing ↗